Citigroup Inc X Biotech Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Citigroup Inc holds 15,369 shares of XBIT stock, worth $47,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,369
Previous 14,517
5.87%
Holding current value
$47,029
Previous $112,000
46.43%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XBIT
# of Institutions
54Shares Held
4.7MCall Options Held
200Put Options Held
12.8K-
Black Rock Inc. New York, NY1.13MShares$3.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$3.26 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA455KShares$1.39 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny264KShares$806,3770.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$759,7060.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $93.1M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...